Literature DB >> 18093958

Profile of Mark E. Davis.

Farooq Ahmed.   

Abstract

Mesh：

Year:  2007        PMID： 18093958      PMCID： PMC2409208          DOI： 10.1073/pnas.0704959105

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN： 0027-8424            Impact factor:   11.205


× No keyword cloud information.
  4 in total

1.  Molecular imprinting of bulk, microporous silica

Authors: 
Journal:  Nature       Date:  2000-01-20       Impact factor: 49.962

2.  Sequence-specific knockdown of EWS-FLI1 by targeted, nonviral delivery of small interfering RNA inhibits tumor growth in a murine model of metastatic Ewing's sarcoma.

Authors:  Siwen Hu-Lieskovan; Jeremy D Heidel; Derek W Bartlett; Mark E Davis; Timothy J Triche
Journal:  Cancer Res       Date:  2005-10-01       Impact factor: 12.701

3.  Preclinical efficacy of the camptothecin-polymer conjugate IT-101 in multiple cancer models.

Authors:  Thomas Schluep; Jungyeong Hwang; Jianjun Cheng; Jeremy D Heidel; Derek W Bartlett; Beth Hollister; Mark E Davis
Journal:  Clin Cancer Res       Date:  2006-03-01       Impact factor: 12.531

4.  Administration in non-human primates of escalating intravenous doses of targeted nanoparticles containing ribonucleotide reductase subunit M2 siRNA.

Authors:  Jeremy D Heidel; Zhongping Yu; Joanna Yi-Ching Liu; Shyam M Rele; Yongchao Liang; Ryan K Zeidan; Douglas J Kornbrust; Mark E Davis
Journal:  Proc Natl Acad Sci U S A       Date:  2007-03-22       Impact factor: 11.205
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.